EUVIMEDEUVIMED entdecken
Crossref

Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank

Elie Rassy, Suzette Delaloge, Mojgan Karimi, Thérèse Truong, Emilien Gauthier, Stéphane Ragusa, Damien Drubay, Paul Pharoah, Stefan Michiels, Maryam Karimi

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.116096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Elie Rassy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gustave Roussy, Department of cancer Medicine, Villejuif F-94805, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre…. Hauptthemen laut MEDLINE: Breast Neoplasms, Early Detection of Cancer, Multifactorial Inheritance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEarly Detection of CancerMultifactorial InheritanceAdultAgedFemaleHumansMiddle AgedBiological Specimen BanksGenetic Predisposition to DiseaseGenetic Risk ScoreRisk AssessmentRisk FactorsUK BiobankUnited Kingdom

Stichwörter der Autor:innen

AncestryBreast cancerClinical scoresPolygenic risk scoresRisk modelling

Autor:innen und Institutionen

  • Gustave Roussy, Department of cancer Medicine, Villejuif F-94805, France; Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France. Electronic address: elie.el-rassy@gusta…
  • Gustave Roussy, Department of cancer Medicine, Villejuif F-94805, France; Interception programme, Gustave Roussy, Villejuif, France.
  • Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
  • Predilife, Villejuif, France.
  • Inserm, Université Paris-Saclay, CESP U1018, Oncostat, labeled Ligue Contre le Cancer, Villejuif, France; Gustave Roussy, Office of Biostatistics and Epidemiology, Université Paris-Saclay, Villejuif, France.
  • Department of Computational Biomedicine, Cedars-Sinai Medical Center, CA 90048, United States.

Zitieren

APA

Rassy, E., Delaloge, S., Karimi, M., Truong, T., Gauthier, E., Ragusa, S., Drubay, D., Pharoah, P., Michiels, S., & Karimi, M. (2025). Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116096

Vancouver

Rassy E, Delaloge S, Karimi M, Truong T, Gauthier E, Ragusa S, et al. Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116096

BibTeX
@article{Rassy2025,
  author = {Rassy, Elie and Delaloge, Suzette and Karimi, Mojgan and Truong, Thérèse and Gauthier, Emilien and Ragusa, Stéphane and Drubay, Damien and Pharoah, Paul and Michiels, Stefan and Karimi, Maryam},
  title = {Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313 for breast cancer risk prediction in UK Biobank},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.116096}
}
Kostenlos starten →